You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賽生藥業(06600.HK):2022年純利8.55億元 末期息每股0.39港元
格隆匯 03-30 23:43

格隆匯3月30日丨賽生藥業(06600.HK)發佈公吿,截至2022年12月31日止年度,集團收入約為人民幣27.5億元,較去年增長約9.2%,自2017年集團重組以來連續第五年錄得約雙位數增長;毛利同比增長約7.1%至約人民幣20.71億元;每股基本盈利約為人民幣1.27元,擬派付末期股息每股0.39港元。

報吿期內,純利約為人民幣8.55億元,較去年減少約人民幣6800萬元。撇除投資的公允價值虧損變動人民幣8050萬元及經考慮其進一步開發的不確定性而對相關無形資產計提全額減值虧損人民幣9950萬元後,一般業務經營核心純利約為人民幣10.35億元,較去年增長約5.6%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account